Inês Mariana Lourenço

ORCID: 0000-0003-0752-0802
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Metabolism, Diabetes, and Cancer
  • Diabetes Treatment and Management
  • Diet and metabolism studies
  • Alcohol Consumption and Health Effects
  • Pancreatic function and diabetes
  • Ion channel regulation and function
  • Amino Acid Enzymes and Metabolism
  • Hip and Femur Fractures
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Screening and Detection
  • Esophageal Cancer Research and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Diversity and Career in Medicine
  • Growth Hormone and Insulin-like Growth Factors
  • Thyroid Disorders and Treatments

Universidade do Porto
2023-2025

Diabetes Australia
2023

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly prevalent and the most common cause of chronic in western world. It considered hepatic manifestation metabolic syndrome ultimately leads to cardiovascular diseases, which are leading death. Heart failure with preserved ejection fraction (HFpEF) appears be a complication MASLD and, conversely, seems exacerbate its severity. This review focuses on pathophysiological association between HFpEF, as well...

10.1159/000541442 article EN cc-by Deleted Journal 2024-09-18

Background: Low levels of triiodothyronine (T3) are common in patients with heart failure (HF). Our aim was to evaluate the effects supplementation low and replacement doses T3 an animal model HF preserved ejection fraction (HFpEF). Methods: We evaluated four groups: ZSF1 Lean (n = 8, Lean-Ctrl), Obese (rat metabolic-induced HFpEF, n 13, HFpEF), treated a dose HFpEF-T3high), low-dose HFpEF-T3low). administered drinking water from weeks 13 24. The animals underwent anthropometric metabolic...

10.1089/thy.2022.0717 article EN Thyroid 2023-05-04

Introduction: Data regarding the referral of patients with metabolic syndrome (MetS) to hepatologists is scarce.Most authors agree that at-risk (including ones diabetes or MetS) should be screened for non-alcoholic fatty liver disease (NAFLD) and referred when needed.Existing data highlights NAFLD specialists remain low among endocrinologists.Our aim was evaluate a Portuguese cohort MetS followed in Endocrinology outpatient setting their need hepatologists.Methods: Secondary analysis...

10.26497/ao230023 article EN Revista Portuguesa de Endocrinologia Diabetes e Metabolismo 2023-01-01
Coming Soon ...